Literature DB >> 20336713

Hepatitis C virus core protein compromises iron-induced activation of antioxidants in mice and HepG2 cells.

Kyoji Moriya1, Hideyuki Miyoshi, Seiko Shinzawa, Takeya Tsutsumi, Hajime Fujie, Koji Goto, Yoshizumi Shintani, Hiroshi Yotsuyanagi, Kazuhiko Koike.   

Abstract

One of the characteristics of hepatitis C virus (HCV) infection is the unusual augmentation of oxidative stress, which is exacerbated by iron accumulation in the liver, as observed frequently in hepatitis C patients. Using a transgenic mouse model, the core protein of HCV was shown previously to induce the overproduction of reactive oxygen species (ROS) in the liver. In the present study, the impact of iron overloading on the oxidant/antioxidant system was examined using this mouse model and cultured cells. Iron overloading caused the induction of ROS as well as antioxidants. However, the augmentation of some antioxidants, including heme oxygenase-1 and NADH dehydrogenase, quinone 1, was compromised by the presence of the core protein. The attenuation of iron-induced augmentation of heme oxygenase-1 was also confirmed in HepG2 cells expressing the core protein. This attenuation was not dependent on the Nrf2 transcription factor. Thus, HCV infection not only induces oxidative stress but also hampers the iron-induced antioxidant activation in the liver, thereby exacerbating oxidative stress that would facilitate hepatocarcinogenesis. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20336713     DOI: 10.1002/jmv.21661

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

1.  Interactions Between Hepatitis C Virus and Mitochondria: Impact on Pathogenesis and Innate Immunity.

Authors:  Ting Wang; Steven A Weinman
Journal:  Curr Pathobiol Rep       Date:  2013-09

Review 2.  Role of Nrf2 in chronic liver disease.

Authors:  Wei Tang; Yong-Fang Jiang; Murugavel Ponnusamy; Mamadou Diallo
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  A complex signaling network involving protein kinase CK2 is required for hepatitis C virus core protein-mediated modulation of the iron-regulatory hepcidin gene expression.

Authors:  Pelagia Foka; Alexios Dimitriadis; Eleni Kyratzopoulou; Dionysios A Giannimaras; Stefania Sarno; George Simos; Urania Georgopoulou; Avgi Mamalaki
Journal:  Cell Mol Life Sci       Date:  2014-04-10       Impact factor: 9.261

4.  IL28B, HCV core mutations, and hepatocellular carcinoma: does host genetic make-up shape viral evolution in response to immunity?

Authors:  Luca Valenti; Edoardo Pulixi; Susanna La Spina
Journal:  Hepatol Int       Date:  2011-12-07       Impact factor: 6.047

Review 5.  Iron-Induced Hepatocarcinogenesis-Preventive Effects of Nutrients.

Authors:  Hiroyuki Tsuchiya
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

Review 6.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

7.  Recent advances in liver preconditioning: Thyroid hormone, n-3 long-chain polyunsaturated fatty acids and iron.

Authors:  Virginia Fernández; Gladys Tapia; Luis A Videla
Journal:  World J Hepatol       Date:  2012-04-27

Review 8.  Hepcidin and Host Defense against Infectious Diseases.

Authors:  Kathryn Michels; Elizabeta Nemeth; Tomas Ganz; Borna Mehrad
Journal:  PLoS Pathog       Date:  2015-08-20       Impact factor: 6.823

Review 9.  Mitochondrial Proteins Coded by Human Tumor Viruses.

Authors:  Ilaria Cavallari; Gloria Scattolin; Micol Silic-Benussi; Vittoria Raimondi; Donna M D'Agostino; Vincenzo Ciminale
Journal:  Front Microbiol       Date:  2018-02-06       Impact factor: 5.640

Review 10.  Hepcidin and the iron enigma in HCV infection.

Authors:  Urania Georgopoulou; Alexios Dimitriadis; Pelagia Foka; Eirini Karamichali; Avgi Mamalaki
Journal:  Virulence       Date:  2014-03-13       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.